MCK
McKessonPrevious close
994.58
Change
+13.70 / +1.40%
P/E (TTM) ?
25.5
Market Cap
$117B
1M
+16.49%
S&P 500 −0.91% over same period
Volume / Avg Volume
764K / 685K
1.12× average
Latest earnings analysisFY2027 Q1Reported 2026-08-05
McKesson Q1 FY2027: adjusted EPS up 20.0%, guidance raised, GAAP EPS down 18.0%
McKesson's adjusted profit grew 20.0% and management raised full-year guidance, so this quarter is a beat on the numbers investors watch most. The catch is the gap between adjusted and reported results: GAAP net income fell 22.0%, driven mostly by a $293 million charge tied to selling a slice of the medical-surgical business. Free cash flow was also negative at -$372 million, so read the two profit lines together, not one alone.
Read the full analysis →Revenue$105.38BYoY +7.70%
EPS (non-GAAP)$9.93Beatest. $9.63
Next-day move−0.67%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2027 Q1 Quarter ended 2026-06 | 2026-08-05 | $105B | Read analysis → |
| FY2026 Q4 Quarter ended 2026-03 | 2026-05-07 | $403B | Pending |
| FY2026 Q3 Quarter ended 2025-12 | 2026-02-04 | $106B | Pending |
| FY2026 Q2 Quarter ended 2025-09 | 2025-11-05 | $103B | Pending |
| — | 2025-09-18 | — | No analysis |
| FY2026 Q1 Quarter ended 2025-06 | 2025-08-06 | $97.8B | Pending |
| FY2025 Q4 Quarter ended 2025-03 | 2025-05-09 | $359B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 51 of its 5-year rangeMid-range
5-year range 16.7 – 31.8 · Median 25.3
Last 4 quarters: $6.7B in buybacks + $393M in dividends, 6.08% of market cap combined
P/E (TTM)
25.5
P/B
19.9
P/S
0.3
Dividend Yield
0.54%
Earnings Reaction
Over the last 7 reports, the stock moved ±4.2% on average on the first trading day after, rising 3 times
Most recent −0.67%
Volatility & Correlation
1-year beta -0.29 · Correlation with S&P 500 -0.12Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $1.2MNet selling $1.2M
- 10-15Fraga FranciscoEVP, CIO and CTOSell$0.80M800.491 shares · Avg price 995.80
- 09-08Rutledge Napoleon B JRSVP, Controller & CAOSell$0.10M111 shares · Avg price 891.45
- 08-10Lerman Bradley EDirectorSell$0.27M301 shares · Avg price 892.33
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2027 Q1 | 105.38 | +7.7% | 3.5% | 0.61 | 5.15 |
| FY2026 Q4 | 96.30 | +6.0% | 4.2% | 1.68 | 13.62 |
| FY2026 Q3 | 106.16 | +11.4% | 3.5% | 1.19 | 9.59 |
| FY2026 Q2 | 103.15 | +10.1% | 3.4% | 1.11 | 8.92 |
| FY2026 Q1 | 97.83 | +23.4% | 3.4% | 0.78 | 6.25 |
| FY2025 Q4 | 90.82 | +18.9% | 4.0% | 1.26 | 9.90 |
| FY2025 Q3 | 95.29 | +17.8% | 3.4% | 0.88 | 6.95 |
| FY2025 Q2 | 93.65 | +21.3% | 3.5% | 0.24 | 1.87 |
| FY2025 Q1 | 79.28 | +6.4% | 4.0% | 0.92 | 7.00 |
| FY2024 Q4 | 76.36 | +10.8% | 4.7% | 0.79 | 6.03 |
| FY2024 Q3 | 80.90 | +14.8% | 3.9% | 0.59 | 4.42 |
| FY2024 Q2 | 77.22 | +10.1% | 4.0% | 0.66 | 4.92 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| MCK | 25.5 | +7.7% | 3.5% | +16.49% | Bullish |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |